48,803
edits
(→IHC) |
(→IHC) |
||
Line 148: | Line 148: | ||
*EMA -ve. | *EMA -ve. | ||
**SCC usually positive.<ref name=pmid10971697>{{Cite journal | last1 = Beer | first1 = TW. | last2 = Shepherd | first2 = P. | last3 = Theaker | first3 = JM. | title = Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. | journal = Histopathology | volume = 37 | issue = 3 | pages = 218-23 | month = Sep | year = 2000 | doi = | PMID = 10971697 }}</ref> | **SCC usually positive.<ref name=pmid10971697>{{Cite journal | last1 = Beer | first1 = TW. | last2 = Shepherd | first2 = P. | last3 = Theaker | first3 = JM. | title = Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. | journal = Histopathology | volume = 37 | issue = 3 | pages = 218-23 | month = Sep | year = 2000 | doi = | PMID = 10971697 }}</ref> | ||
*SMA +ve.<ref>URL: [http://www.ihcworld.com/_newsletter/2004/2004-12_basal_cell_vs_squamous_v1.pdf http://www.ihcworld.com/_newsletter/2004/2004-12_basal_cell_vs_squamous_v1.pdf]. Accessed on: 19 December 2012.</ref> | |||
**SCC usually negative. | |||
===Sign-out=== | ===Sign-out=== |
edits